Answers are grounded in this paper and cite their sources.
Reveals hsa_circ_0070354 facilitates tumor growth in NSCLC, indicating a potential intervention target.
BACKGROUND: Circular RNA (hsa_circ_0070354), also known as circPTPN13, was demonstrated in our previous study that it can be used as a biomarker for diagnosing non-small cell lung cancer (NSCLC). However, the mechanism of its role in the occurrence and development of NSCLC has not been investigated. METHODS AND RESULTS: The cell functions of NSCLC cells are evaluated by transfecting with relevant mimics, inhibitors, or plasmids in cell lines. After knocking down hsa_circ_0070354, the expression of miR-4322 increased, and RAB3B decreased, and the expression changed inversely after overexpression of hsa_circ_0070354. Mechanically, hsa_circ_0070354 acts as a ceRNA to adsorb miR-4322 and modulate Ras-Related Protein Rab-3B (RAB3B) to facilitate the proliferation, migration, invasion, and EMT of NSCLC cells. MiR-4322 or RAB3B inhibition restored proliferation, migration, and invasion of NSCLC cells after silencing of hsa_circ_0070354. In addition, hsa_circ_0070354 knockdown suppressed tumor growth in vivo. CONCLUSIONS: Collectively, our study reveals a promotive role of hsa_circ_0070354 in tumor proliferation, invasion, and migration by regulating the miR-4322/RAB3B axis and highlights that targeting the axis is a promising strategy for the intervention of NSCLC progression.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: